Cargando…
Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
Glioblastoma (GBM) is the most common primary brain tumor in adults an carries and carries a terrible prognosis. The current regiment of surgical resection, radiation, and chemotherapy has remained largely unchanged in recent years as new therapeutic approaches have struggled to demonstrate benefit....
Autores principales: | Himes, Benjamin T., Geiger, Philipp A., Ayasoufi, Katayoun, Bhargav, Adip G., Brown, Desmond A., Parney, Ian F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581618/ https://www.ncbi.nlm.nih.gov/pubmed/34778089 http://dx.doi.org/10.3389/fonc.2021.770561 |
Ejemplares similares
-
Superinduction of immunosuppressive glioblastoma extracellular vesicles by IFN-γ through PD-L1 and IDO1
por: Jung, Mi-Yeon, et al.
Publicado: (2022) -
The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma
por: Neth, Bryan J., et al.
Publicado: (2023) -
Mechanical Properties in the Glioma Microenvironment: Emerging Insights and Theranostic Opportunities
por: Bhargav, Adip G., et al.
Publicado: (2022) -
Harnessing Radiation Biology to Augment Immunotherapy for Glioblastoma
por: Rajani, Karishma R., et al.
Publicado: (2019) -
Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma
por: Padfield, Emily, et al.
Publicado: (2015)